• XELL Deutschland
  • XELL English
  • XELL China

Maximizing process yields: Trust Xell with our ideal combination of R&D services!

High-performance cell culture media for the production of monoclonal antibodies – and vaccines or viral vectors for gene therapy applications especially – are more relevant than ever. One efficient approach to increase process yields is to select the most suitable medium – or even better, to utilize a completely customized medium. By leveraging Xell’s long-standing […]

Read More…


The journey to AAV production in suspension: Scale up your process

Adeno-Associated Viral vectors (AAV) are among the most widely used vectors for gene therapy applications and their importance has become even more evident recently. To support you in your process scale-up, we address questions like “Why should you consider transferring your AAV production from adherent to suspension?” and discuss different case studies (AAV-2 and AAV-8) […]

Read More…


The key to an easier scale-up: Suspension-adapted cells

Traditional mammalian cell culture is usually anchor-dependent and serum-supplemented, which is directly connected to a series of disadvantages, due to the serum/ animal derived components. In contrast, suspension cultures in animal-derived component free (ADCF) cell culture media have several advantages: reduced lot-to-lot variability of the medium easier scale-up no risk of blood-borne pathogens massively reduced […]

Read More…


Keeping your project on time and up-to-date with Xell’s transparent ordering process

Have your liquid or dry powder production requirements fulfilled by our dedicated teams of experts: Transform your ideas into high-performance materials with the support of our product engineers Reliable lead times guaranteed by our manufacturing team Material compliance through continuous examination carried out by our analytical department Get the documentation you need to meet your […]

Read More…


The highest quality and shortest response times – Xell’s powder production

Tap into the resources provided by our state-of-the-art dry powder line: 100% animal origin-free (AOF) production Flexibility with batch and packaging sizes Customization to meet your project requirements Scalability; from prototype 1 kg/batch to 1,000 kg/batch (≈ 40,000 – 50,000 L medium) A capable team of engineers and scientists, at your disposal Transparent process steps […]

Read More…